Activation of microglia and induction of pro-inflammatory cytokines in the hippocampus of type 2 diabetic rats

References

• Davis EJ, Foster TD, Thomas WE. Cellular forms and functions of brain microglia. Brain Res Bull. 1994;34:73–8.
   PubMed Web of Science ®Google Scholar
• Block ML, Hong JS. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol. 2005;76:77–98.
   PubMed Web of Science ®Google Scholar
• Gehrmann J, Banati RB, Wiessner C, Hossmann KA, Kreutzberg GW. Reactive microglia in cerebral ischaemia: an early mediator of tissue damage? Neuropathol Appl Neurobiol. 1995;21:277–89.
   PubMed Web of Science ®Google Scholar
• Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996;19:312–8.
   PubMed Web of Science ®Google Scholar
• Boche D, Perry VH, Nicoll JA. Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol. 2013;39:3–18.
   PubMed Web of Science ®Google Scholar
• Schöbitz B, De Kloet ER, Holsboer F. Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain. Prog Neurobiol. 1994;44:397–432.
   PubMed Web of Science ®Google Scholar
• Hopkins SJ, Rothwell NJ. Cytokine and the nervous system I: expression and recognition. Trends Neurosci. 1995;18:83–8.
   PubMed Web of Science ®Google Scholar
• Benveniste EN, Benos DJ. TNF-α- and IFN-γ-mediated signal transduction pathways: effects on glial cell gene expression and function. FASEB J. 1995;9:1577–84.
   PubMed Web of Science ®Google Scholar
• Neumann H. Control of glial immune function by neurons. Glia. 2001;36:191–9.
   PubMed Web of Science ®Google Scholar
• Mrak RE, Griffin WS. Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging. 2005;26:349–54.
   PubMed Web of Science ®Google Scholar
• Porterfield VM, Gabella KM, Simmons MA, Johnson JD. Repeated stressor exposure regionally enhances beta-adrenergic receptor-mediated brain IL-1β production. Brain Behav Immun. 2012;26:1249–55.
   PubMed Web of Science ®Google Scholar
• Del Rey A, Apkarian AV, Martina M, Besedovsky HO. Chronic neuropathic pain-like behavior and brain-borne IL-1β. Ann N Y Acad Sci. 2012;1262:101–7.
   PubMed Web of Science ®Google Scholar
• Chao PK, Lu KT, Jhu JY, Wo YY, Huang TC, Ro LS, et al. Indomethacin protects rats from neuronal damage induced by traumatic brain injury and suppresses hippocampal IL-1β release through the inhibition of Nogo-A expression. J Neuroinflammation. 2012;9:121.
   PubMed Web of Science ®Google Scholar
• Szczytkowski JL, Lebonville C, Hutson L, Fuchs RA, Lysle DT. Heroin-induced conditioned immunomodulation requires expression of IL-1β in the dorsal hippocampus. Brain Behav Immun. 2013;30:95–102.
   PubMed Web of Science ®Google Scholar
• Cribbs DH, Berchtold NC, Perreau V, Coleman PD, Rogers J, Tenner AJ, et al. Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study. J Neuroinflammation. 2012;9:179.
   PubMed Web of Science ®Google Scholar
• Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, et al. Inflammation and Alzheimer’s disease. Neurobiol Aging. 2000;21:383–421.
   PubMed Web of Science ®Google Scholar
• Griffin WS, Sheng JG, Royston MC, Gentleman SM, McKenzie JE, Graham DI, et al. Glial-neuronal interactions in Alzheimer’s disease: the potential role of a ‘cytokine cycle’ in disease progression. Brain Pathol. 1998;8:65–72.
   PubMed Web of Science ®Google Scholar
• Griffin WS, Mrak RE. Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer’s disease. J Leukoc Biol. 2002;72:233–8.
   PubMed Web of Science ®Google Scholar
• Rogers J, Mastroeni D, Leonard B, Joyce J, Grover A. Neuroinflammation in Alzheimer’s disease and Parkinson’s disease: are microglia pathogenic in either disorder? Int Rev Neurobiol. 2007;82:235–46.
   PubMed Web of Science ®Google Scholar
• Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG, Lukiw WJ. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res. 2002;70:462–73.
   PubMed Web of Science ®Google Scholar
• Ricciarelli R, d’Abramo C, Massone S, Marinari U, Pronzato M, Tabaton M. Microarray analysis in Alzheimer’s disease and normal aging. IUBMB Life. 2004;56:349–54.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Kiyota T, Horiba M, Buescher JL, Walsh SM, Gendelman HE, et al. Interferon-γ and tumor necrosis factor-α regulate amyloid-β plaque deposition and β-secretase expression in Swedish mutant APP transgenic mice. Am J Pathol. 2007;170:680–92.
   PubMed Web of Science ®Google Scholar
• Griffin WS, Nicoll JA, Grimaldi LM, Sheng JG, Mrak RE. The pervasiveness of interleukin-1 in Alzheimer pathogenesis: a role for specific polymorphisms in disease risk. Exp Gerontol. 2000;35:481–7.
   PubMed Web of Science ®Google Scholar
• Kilander L, Nyman H, Boberg M, Lithell H. Cognitive function, vascular risk factors and education. A cross-sectional study based on a cohort of 70-year-old men. J Intern Med. 1997;242:313–21.
   PubMed Web of Science ®Google Scholar
• Messier C, Awad N, Gagnon M. The relationships between atherosclerosis, heart disease, type 2 diabetes and dementia. Neurol Res. 2004;26:567–72.
   PubMed Web of Science ®Google Scholar
• Rönnemaa E, Zethelius B, Sundelöf J, Sundström J, Degerman-Gunnarsson M, Berne C, et al. Impaired insulin secretion increases the risk of Alzheimer disease. Neurology. 2008;71:1065–71.
   PubMed Web of Science ®Google Scholar
• Van den Berg E, Kessels RP, Kappelle LJ, de Haan EH, Biessels GJ, Utrecht Diabetic Encephalopathy Study Group. Type 2 diabetes, cognitive function and dementia: vascular and metabolic determinants. Drugs Today (Barc). 2006;42:741–54.
   PubMed Web of Science ®Google Scholar
• Li XL, Aou S, Oomura Y, Hori N, Fukunaga K, Hori T. Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents. Neuroscience. 2002;113:607–15.
   PubMed Web of Science ®Google Scholar
• Clodfelder-Miller BJ, Zmijewska AA, Johnson GV, Jope RS. Tau is hyperphosphorylated at multiple sites in mouse brain in vivo after streptozotocin-induced insulin deficiency. Diabetes. 2006;55:3320–5.
   PubMed Web of Science ®Google Scholar
• Li ZG, Zhang W, Sima AA. Alzheimer-like changes in rat models of spontaneous diabetes. Diabetes. 2007;56:1817–24.
   PubMed Web of Science ®Google Scholar
• Planel E, Tatebayashi Y, Miyasaka T, Liu L, Wang L, Herman M, et al. Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms. J Neurosci. 2007;27:13635–48.
   PubMed Web of Science ®Google Scholar
• Stranahan AM, Arumugam TV, Cutler RG, Lee K, Egan JM, Mattson MP. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat Neurosci. 2008;11:309–17.
   PubMed Web of Science ®Google Scholar
• Stewart R, Liolitsa D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med. 1999;16:93–112.
   PubMed Web of Science ®Google Scholar
• Li L, Hölscher C. Common pathological processes in Alzheimer disease and type 2 diabetes: a review. Brain Res Rev. 2007;56:384–402.
   PubMedGoogle Scholar
• Moreira RO, Campos SC, Soldera AL. Type 2 diabetes mellitus and Alzheimer’s disease: from physiopathology to treatment implications. Diabetes Metab Res Rev. 2013; doi: 10.1002/dmrr.2442 [Epub ahead of print].
   PubMedGoogle Scholar
• Mastrocola R, Restivo F, Vercellinatto I, Danni O, Brignardello E, Aragno M, et al. Oxidative and nitrosative stress in brain mitochondria of diabetic rats. J Endocrinol. 2005;187:37–44.
   PubMed Web of Science ®Google Scholar
• Somfai GM, Knippel B, Ruzicska E, Stadler K, Tóth M, Salacz G, et al. Soluble semicarbazide-sensitive amine oxidase (SSAO) activity is related to oxidative stress and subchronic inflammation in streptozotocin-induced diabetic rats. Neurochem Int. 2006;48:746–52.
   PubMed Web of Science ®Google Scholar
• Temelkova-Kurktschiev T, Henkel E, Koehler C, Karrei K, Hanefeld M. Subclinical inflammation in newly detected Type II diabetes and impaired glucose tolerance. Diabetologia. 2002;45:151.
   PubMed Web of Science ®Google Scholar
• Hwang IK, Yi SS, Kim YN, Kim IY, Lee IS, Yoon YS, et al. Reduced hippocampal cell differentiation in the subgranular zone of the dentate gyrus in a rat model of type II diabetes. Neurochem Res. 2008;33:394–400.
   PubMed Web of Science ®Google Scholar
• Yi SS, Hwang IK, Chun MS, Kim YN, Kim IY, Lee IS, et al. Glucocorticoid receptor changes associate with age in the paraventricular nucleus of type II diabetic rat model. Neurochem Res. 2009;34:851–8.
   PubMed Web of Science ®Google Scholar
• Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Amsterdam: Elsevier Academic Press; 2007.
   Google Scholar
• Bruehl H, Rueger M, Dziobek I, Sweat V, Tirsi A, Javier E, et al. Hypothalamic-pituitary-adrenal axis dysregulation and memory impairments in type 2 diabetes. J Clin Endocrinol Metab. 2007;92:2439–45.
   PubMed Web of Science ®Google Scholar
• Debling D, Amelang M, Hasselbach P, Stürmer T. Diabetes and cognitive function in a population-based study of elderly women and men. J Diabetes Complications. 2006;20:238–45.
   PubMed Web of Science ®Google Scholar
• Bruehl H, Wolf OT, Sweat V, Tirsi A, Richardson S, Convit A. Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. Brain Res. 2009;1280:186–94.
   PubMed Web of Science ®Google Scholar
• Kodl CT, Seaquist ER. Cognitive dysfunction and diabetes mellitus. Endocr Rev. 2008;29:494–511.
   PubMed Web of Science ®Google Scholar
• Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T. New inbred strain of Long–Evans Tokushima lean rats with IDDM without lymphopenia. Diabetes. 1991;40:1375–81.
   PubMed Web of Science ®Google Scholar
• Abrahám H, Losonczy A, Czéh G, Lázár G. Rapid activation of microglial cells by hypoxia, kainic acid, and potassium ions in slice preparations of the rat hippocampus. Brain Res. 2001;906:115–26.
   PubMed Web of Science ®Google Scholar
• Cho BP, Sugama S, Shin DH, DeGiorgio LA, Kim SS, Kim YS, et al. Microglial phagocytosis of dopamine neurons at early phases of apoptosis. Cell Mol Neurobiol. 2003;23:551–60.
   PubMed Web of Science ®Google Scholar
• Cho BP, Song DY, Sugama S, Shin DH, Shimizu Y, Kim SS, et al. Pathological dynamics of activated microglia following medial forebrain bundle transection. Glia. 2006;53:92–102.
   PubMed Web of Science ®Google Scholar
• Graeber MB, Streit WJ, Kreutzberg GW. Axotomy of the rat facial nerve leads to increased CR3 complement receptor expression by activated microglial cells. J Neurosci Res. 1988;21:18–24.
   PubMed Web of Science ®Google Scholar
• Shaw JA, Perry VH, Mellanby J. Tetanus toxin-induced seizures cause microglial activation in rat hippocampus. Neurosci Lett. 1990;120:66–9.
   PubMed Web of Science ®Google Scholar
• Sugama S, Cho BP, Degiorgio LA, Shimizu Y, Kim SS, Kim YS, et al. Temporal and sequential analysis of microglia in the substantia nigra following medial forebrain bundle axotomy in rat. Neuroscience. 2003;116:925–33.
   PubMed Web of Science ®Google Scholar
• Zucconi GG, Laurenzi MA, Semprevivo M, Torni F, Lindgren JA, Marinucci E. Microglia activation and cell death in response to diethyl-dithiocarbamate acute administration. J Comp Neurol. 2002;446:135–50.
   PubMed Web of Science ®Google Scholar
• Choi JH, Lee CH, Hwang IK, Won MH, Seong JK, Yoon YS, et al. Age-related changes in ionized calcium-binding adapter molecule 1 immunoreactivity and protein level in the gerbil hippocampal CA1 region. J Vet Med Sci. 2007;69:1131–6.
   PubMed Web of Science ®Google Scholar
• Hwang IK, Lee CH, Li H, Yoo KY, Choi JH, Kim DW, et al. Comparison of ionized calcium-binding adapter molecule 1 immunoreactivity of the hippocampal dentate gyrus and CA1 region in adult and aged dogs. Neurochem Res. 2008;33:1309–15.
   PubMed Web of Science ®Google Scholar
• Yoon SY, Park JS, Choi JE, Choi JM, Lee WJ, Kim SW, et al. Rosiglitazone reduces tau phosphorylation via JNK inhibition in the hippocampus of rats with type 2 diabetes and tau transfected SH-SY5Y cells. Neurobiol Dis. 2010;40:449–55.
   PubMed Web of Science ®Google Scholar
• Dinkel K, MacPherson A, Sapolsky RM. Novel glucocorticoid effects on acute inflammation in the CNS. J Neurochem. 2003;84:705–16.
   PubMed Web of Science ®Google Scholar
• Nair A, Bonneau RH. Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation. J Neuroimmunol. 2006;171:72–85.
   PubMed Web of Science ®Google Scholar
• Hwang IK, Yi SS, Yoo KY, Park OK, Yan B, Song W, et al. Effect of treadmill exercise on blood glucose, serum corticosterone levels and glucocorticoid receptor immunoreactivity in the hippocampus in chronic diabetic rats. Neurochem Res. 2011;36:281–7.
   PubMed Web of Science ®Google Scholar
• Wei YP, Kita M, Shinmura K, Yan XQ, Fukuyama R, Fushiki S, et al. Expression of IFN-γ in cerebrovascular endothelial cells from aged mice. J Interferon Cytokine Res. 2000;20:403–9.
   PubMed Web of Science ®Google Scholar
• Hashioka S, Han YH, Fujii S, Kato T, Monji A, Utsumi H, et al. Phosphatidylserine and phosphatidylcholine-containing liposomes inhibit amyloid β and interferon-γ-induced microglial activation. Free Radic Biol Med. 2007;42:945–54.
   PubMed Web of Science ®Google Scholar
• Meda L, Cassatella MA, Szendrei GI, Otvos L Jr, Baron P, Villalba M, et al. Activation of microglial cells by β-amyloid protein and interferon-γ. Nature. 1995;374:647–50.
   PubMed Web of Science ®Google Scholar
• Mrak RE, Sheng JG, Griffin WS. Glial cytokines in Alzheimer’s disease: review and pathogenic implications. Hum Pathol. 1995;26:816–23.
   PubMed Web of Science ®Google Scholar
• Akiyama H, Arai T, Kondo H, Tanno E, Haga C, Ikeda K. Cell mediators of inflammation in the Alzheimer disease brain. Alzheimer Dis Assoc Disord. 2000;14(Suppl 1):S47–53.
   PubMedGoogle Scholar
• Murray C, Lynch MA. Evidence that increased hippocampal expression of the cytokine interleukin-1β is a common trigger for age- and stress-induced impairments in long-term potentiation. J Neurosci. 1998;18:2974–81.
   PubMed Web of Science ®Google Scholar
• Depino AM, Alonso M, Ferrari C, del Rey A, Anthony D, Besedovsky H, et al. Learning modulation by endogenous hippocampal IL-1: blockade of endogenous IL-1 facilitates memory formation. Hippocampus. 2004;14:526–35.
   PubMed Web of Science ®Google Scholar
• Lynch AM, Lynch MA. The age-related increase in IL-1 type I receptor in rat hippocampus is coupled with an increase in caspase-3 activation. Eur J Neurosci. 2001;15:1779–88.
   Web of Science ®Google Scholar
• Koo JW, Duman RS. IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci U S A. 2008;105:751–6.
   PubMed Web of Science ®Google Scholar
• Hwang IK, Yi SS, Song W, Won MH, Yoon YS, Seong JK. Effects of age and treadmill exercise in chronic diabetic stages on neuroblast differentiation in a rat model of type 2 diabetes. Brain Res. 2010;1341:63–71.
   PubMed Web of Science ®Google Scholar
• Razani-Boroujerdi S, Langley RJ, Singh SP, Pena-Philippides JC, Rir-sima-ah J, Gundavarapu S, et al. The role of IL-1β in nicotine-induced immunosuppression and neuroimmune communication. J Neuroimmune Pharmacol. 2011;6:585–96.
   PubMed Web of Science ®Google Scholar